A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy that Is Further Enhanced in Combination with an OX40 Agonist
- Submitting institution
-
Sheffield Hallam University
- Unit of assessment
- 5 - Biological Sciences
- Output identifier
- 3225
- Type
- D - Journal article
- DOI
-
10.1158/1078-0432.CCR-16-2000
- Title of journal
- Clinical Cancer Research
- Article number
- -
- First page
- 3416
- Volume
- 23
- Issue
- 13
- ISSN
- 1078-0432
- Open access status
- Deposit exception
- Month of publication
- July
- Year of publication
- 2017
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
21
- Research group(s)
-
-
- Citation count
- 23
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Lead or corresponding author; Made a substantial contribution to the conception and design of the study; Made a substantial contribution to the organisation of the conduct of the study; Made a substantial contribution to carrying out the study; Made a substantial contribution to analysis and interpretation of study data; Helped draft the output; Helped critique the output for important intellectual content
- Non-English
- No
- English abstract
- -
